SphitiCap, a recently established early-stage VC firm in India, has announced the launch of its debut fund targeting USD 500m.
The firm claims significant traction in terms of soft commitments, with VCCircle reporting that a first close of USD 125m-USD 150m is expected before year-end. Initial investments will be revealed as...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.